HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frank Streit Selected Research

Glial Cell Line-Derived Neurotrophic Factor (GDNF)

11/2018Therapeutic efficacy of regulable GDNF expression for Huntington's and Parkinson's disease by a high-induction, background-free "GeneSwitch" vector.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frank Streit Research Topics

Disease

1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
04/2024
1Demyelinating Diseases (Demyelinating Disease)
04/2024
1Acute Kidney Injury (Acute Renal Failure)
04/2023
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
10/2022
1Intracranial Vasospasm
10/2022
1Neoplasms (Cancer)
12/2021
1Protein Deficiency
05/2021
1Peroxisomal Disorders (Peroxisomal Disorder)
05/2021
1Neuroinflammatory Diseases
01/2021
1Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
01/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2018
1Parkinson Disease (Parkinson's Disease)
11/2018
1Alzheimer Disease (Alzheimer's Disease)
01/2018
1Neonatal Abstinence Syndrome
06/2013
1Infections
02/2013
1Fever (Fevers)
02/2013
1Critical Illness (Critically Ill)
02/2013
1Epstein-Barr Virus Infections
12/2012
1Multiple Sclerosis
12/2012
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
10/2011
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2011
1Obesity
12/2009
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2009
1Multiple Organ Failure (MODS)
11/2007
1Multiple Trauma (Multiple Injuries)
11/2007
1Body Weight (Weight, Body)
08/2005

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2018
1evobrutinibIBA
04/2024
1Nimodipine (Modus)FDA LinkGeneric
10/2022
1Phenobarbital (Luminal)FDA Link
12/2021
1Ether (Diethyl Ether)IBA
12/2021
1Glycerophospholipids (Phosphoglycerides)IBA
12/2021
1EnzymesIBA
05/2021
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2021
1LipidsIBA
01/2021
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
01/2021
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
11/2018
1Nerve Growth Factors (Neurotrophins)IBA
11/2018
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
06/2013
1Anti-Bacterial Agents (Antibiotics)IBA
02/2013
1Meropenem (Merrem)FDA LinkGeneric
02/2013
1LactamsIBA
02/2013
1Vitamin DFDA LinkGeneric
12/2012
1Imatinib Mesylate (Gleevec)FDA Link
10/2011
1GlucocorticoidsIBA
12/2009
111-beta-Hydroxysteroid Dehydrogenase Type 1IBA
12/2009
1Hormones (Hormone)IBA
12/2009
1monoethylglycinexylidide (L 86)IBA
11/2007
1Cytochrome P-450 CYP3AIBA
08/2005

Therapy/Procedure

1Continuous Renal Replacement Therapy
04/2023
1Hematopoietic Stem Cell Transplantation
01/2021
1Therapeutics
01/2021